HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprevalence of hantavirus antibodies among chronic hemodialysis patients in the Czech Republic.

Abstract
A total of 348 serum samples were collected from 301 hemodialysis patients with chronic renal failure of four healthcare settings in Western Bohemia. The sera were screened for the presence of hantavirus antibodies using ELISA kits (PROGEN Biotechnik GmbH) with Hantaan and Puumala antigens. Specific anti-Puumala antibodies were detected in five patients (1.7%). Although hantaviruses are known to cause primarily acute renal damage (interstitial nephritis) in Eurasia, chronic effects of hantavirus infection and the detection of specific antibodies in hemodialysis patients have also been reported. Nonetheless, the detection of seropositivity is not proof of an etiological link between hantaviruses and chronic renal failure. The hantavirus seropositivity rate in hemodialysis patients was not significantly higher than that in the general population. Our findings are consistent with the literature data and do not contradict the contribution of hantaviruses to the pathogenesis of chronic renal damage in the Czech Republic.
AuthorsM Pejcoch, P Pazdiora, J Eiselt, V Hájek, E Veselá, J Vlasák, J Benesová, A Kubátová, B Kríz
JournalEpidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne (Epidemiol Mikrobiol Imunol) Vol. 59 Issue 1 Pg. 48-51 (Feb 2010) ISSN: 1210-7913 [Print] Czech Republic
PMID21105569 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral (blood)
  • Czech Republic (epidemiology)
  • Female
  • Orthohantavirus (immunology)
  • Hantavirus Infections (epidemiology)
  • Humans
  • Kidney Diseases
  • Male
  • Middle Aged
  • Renal Dialysis
  • Seroepidemiologic Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: